Sartorius Stedim Biotech signed a deal to acquire the majority stake in AllPure Technologies.
CRISPR-Cas9 can perform its usual tasks more ably, or assume new ones, if it is subjected to protein engineering. The available protein engineering approaches include rational design, directed evolution, and domain fusion.
Team invents biological switch that turns protein expression on at will
New platform designed to initially focus on high-resolution industrial scale processing of therapeutic mRNA.
Sanofi will use Biomunex Pharmaceuticals’ proprietary BiXAb® platform for generating and optimizing bi- and multi-specific antibodies to develop new treatments in immuno-oncology and other therapeutic areas. The companies have signed a licensing agreement whose value...
Virosome-based vaccine is in early clinical development for treating chronic recurrent thrush.
A perfusion process will produce AGT-190, which comprises a neuroprotectant, neurotrophin, fused to a protein that can carry it across the blood-brain barrier.
AgResearch will create transgenic founder animals for production. GTC Biotherapeutics entered into a collaboration with AgResearch to develop transgenic founder animals for the production of two follow-on biologic (FOB) mAbs. GTC points out that securing...
Please wait while you are redirected to the right page...